Introduction We conducted a systematic literature review and meta‐analysis of empirical
evidence on expected and experienced implications of sharing Alzheimer's disease (AD) …

Alzheimer's disease is increasing in prevalence disproportionately to longevity, placing
enormous burden on individuals, families, healthcare systems and the economy …

Importance Amyloid positron emission tomography (PET) allows the direct assessment of
amyloid deposition, one of the main hallmarks of Alzheimer disease. However, this …

INTRODUCTION We described patients' and care partners' experiences with Alzheimer's
disease (AD) cerebrospinal fluid (CSF) biomarker testing and result disclosure in routine …

Background: Understanding research participants' responses to learning Alzheimer's
disease (AD) risk information is important to inform clinical implementation of precision …

Several lines of evidence have indicated that depression might be a prodromal symptom of
Alzheimer's disease (AD). This systematic review and meta-analysis investigated the cross …

Background: Positron emission tomography (PET) scans for amyloid-β can aid in the early
and accurate detection of Alzheimer disease. The results of amyloid PET scans could help …

Abstract Background Prior studies of Alzheimer's disease (AD) biomarker disclosure have
answered important questions about individuals' safety after learning and comprehending …

Background and Objectives Preclinical Alzheimer disease (AD) trials simultaneously test
candidate treatments and the implications of disclosing biomarker information to cognitively …

Alzheimer disease, unlike conditions like hypertension, must speak to be diagnosed. For
much of the 20th century, diagnosis required a person to recount a story of their own or their …